v.palacios
Submits third-party assay reports on material purchased directly. Based in Lublin.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.99%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042388 | Semaglutide | SWB | SWB-2602-X5278 | Nordanalyt | 2026-Q3 | 98.09 | 3.90 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042195 | Retatrutide | Homopeptide | HOMO-2605-V9833 | Kestrel | 2026-Q3 | 98.99 | 4.02 | 107.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043538 | CJC-1295 with DAC | BCH | BCH-2607-H7307 | Janoshik | 2026-Q3 | 97.92 | 5.97 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041524 | BPC-157 | QYB | QYB-2601-H6381 | VendorInvestigate | 2026-Q2 | 99.93 | 1.87 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042769 | Ipamorelin | GGPeps | GGPE-2508-E9990 | Janoshik | 2026-Q1 | 99.77 | 4.98 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020354 | Liraglutide | MKM | MKM-2508-P3929 | Janoshik | 2025-Q3 | 97.96 | 6.08 | 90.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019243 | TB-500 | TFC | TFC-2412-A6202 | Janoshik | 2025-Q1 | 99.93 | 3.36 | — | Supplier-supplied | 3 | FAIL |